David M. Knott Jr’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

David M. Knott Jr’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-27,190	Closed	-$2.8M	–	161
2023 Q2	$2.8M	Sell	27,190 -14,300	-34%	-$1.51M	1.11%	20
2023 Q1	$4.53M	Buy	41,490 +1,000	+2%	+$111K	1.78%	12
2022 Q4	$4.61M	Sell	40,490 -3,000	-7%	-$249K	1.74%	13
2022 Q3	$2.69M	Hold	43,490	–	–	1.13%	19
2022 Q2	$3.47M	Buy	43,490 +10,000	+30%	+$947K	1.46%	16
2022 Q1	$3.52M	Buy	33,490 +14,490	+76%	+$1.41M	1.12%	22
2021 Q4	$2.05M	Buy	+19,000	New	+$2.07M	0.69%	36

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return